A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Related studies linked through entity extraction aliases.